Daumy G O, Wilder C L, Merenda J M, McColl A S, Geoghegan K F, Otterness I G
Central Research Division, Pfizer Inc., Groton, CT 06340.
FEBS Lett. 1991 Jan 14;278(1):98-102. doi: 10.1016/0014-5793(91)80093-i.
A biologically active preparation of murine recombinant interleukin-1 beta (mIL-1 beta) from Escherichia coli cell lysates contained tow forms of mIL-1 beta with pI 8.7 and pI 8.1, respectively. Treatment with 0.1 M Tris, pH 8.5, at 37 degrees C for 35 h converted the pI 8.7 form to the pI 8.1 form by the selective deamidation of an asparagine residue (Asn149) in the mIL-1 beta molecule. Deamidated mIL-1 beta had 3- to 5-fold lower co-mitogenic activity and receptor affinity than the unmodified form.
一种从大肠杆菌细胞裂解物中制备的具有生物活性的小鼠重组白细胞介素-1β(mIL-1β)制剂含有两种形式的mIL-1β,其等电点分别为8.7和8.1。在37℃下用pH 8.5的0.1 M Tris处理35小时,通过mIL-1β分子中天冬酰胺残基(Asn149)的选择性脱酰胺作用,将等电点8.7的形式转化为等电点8.1的形式。脱酰胺的mIL-1β的共刺激活性和受体亲和力比未修饰形式低3至5倍。